Skip to content

EVOKE PHARMA, INC.: filings

Every EVOKE PHARMA, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 50 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2025-11-13fiscal Q3 202530970001193125-25-278802
10-Q2025-08-14fiscal Q2 202530930000950170-25-108407
10-Q2025-05-13fiscal Q1 202530640000950170-25-070401
10-K2025-03-13fiscal FY 202430600000950170-25-038712
10-Q2024-11-07fiscal Q3 202426880000950170-24-123338
10-Q2024-08-13fiscal Q2 202426840000950170-24-095776
10-Q2024-05-14fiscal Q1 202426550000950170-24-059596
10-K/A2024-05-14fiscal FY 202329800000950170-24-059516
10-K2024-03-14fiscal FY 202328580000950170-24-031435
10-Q2023-11-09fiscal Q3 202327910000950170-23-061578
10-Q2023-08-10fiscal Q2 202327870000950170-23-040998
10-Q2023-05-15fiscal Q1 202327570000950170-23-022182
10-K2023-03-21fiscal FY 202229590000950170-23-008942
10-Q2022-11-09fiscal Q3 202228930000950170-22-023912
10-Q2022-08-10fiscal Q2 202227850001564590-22-028943
10-Q2022-05-10fiscal Q1 202223480001564590-22-019277
10-K2022-03-08fiscal FY 202124470001564590-22-009118
10-Q2021-11-10fiscal Q3 202123690001564590-21-056208
10-Q2021-08-12fiscal Q2 202123660001564590-21-043994
10-Q2021-05-12fiscal Q1 202123450001564590-21-026996
10-K2021-03-11fiscal FY 202023440001564590-21-012510
10-Q2020-11-10fiscal Q3 202021640001564590-20-052754
10-Q2020-08-06fiscal Q2 202020590001564590-20-037301
10-Q2020-05-12fiscal Q1 202018390001564590-20-024523
10-K2020-03-12fiscal FY 201918540001564590-20-010254
10-Q2019-11-07fiscal Q3 201919600001564590-19-041384
10-Q2019-08-08fiscal Q2 201919560001564590-19-030433
10-Q2019-05-08fiscal Q1 201919400001564590-19-017213
10-K2019-03-06fiscal FY 201822780001564590-19-006404
10-Q2018-11-13fiscal Q3 201822660001564590-18-029310
10-Q2018-08-09fiscal Q2 201822650001564590-18-021043
10-Q2018-05-14fiscal Q1 201816330001564590-18-013308
10-K2018-03-07fiscal FY 201720740001564590-18-004725
10-Q2017-11-14fiscal Q3 201720620001564590-17-023771
10-Q2017-08-14fiscal Q2 201720620001564590-17-017663
10-Q2017-05-15fiscal Q1 201716340001564590-17-011039
10-K2017-03-15fiscal FY 201616500001564590-17-004426
10-Q2016-11-09fiscal Q3 201616450001564590-16-028633
10-Q2016-08-15fiscal Q2 201616450001564590-16-024351
10-Q2016-05-11fiscal Q1 201616330001564590-16-019101
10-K2016-03-10fiscal FY 201516500001564590-16-014408
10-Q2015-11-12fiscal Q3 201517500001564590-15-010586
10-Q2015-08-13fiscal Q2 201517480001564590-15-007249
10-Q2015-05-14fiscal Q1 201517350001564590-15-004303
10-K2015-03-04fiscal FY 201418530001564590-15-001287
10-Q2014-11-13fiscal Q3 201418520001564590-14-005646
10-Q2014-08-13fiscal Q2 201417500001193125-14-308400
10-Q2014-05-13fiscal Q1 201419480001193125-14-197023
10-K2014-03-25fiscal FY 201320920001193125-14-114409
10-Q2013-11-13fiscal Q3 201319630001193125-13-440287

Inspect the source

Entity
EVOKE PHARMA, INC. / CIK 0001403708
Captured
2026-09-21T17:19:23.305Z
SEC response SHA-256
1d2ea0edbbb48066d62d49983dacdd25cf55cdf81e3ee5a742e26303a1f7d06e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001403708.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))